A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis

A Randomized, Investigator Blinded Study of Protopic (Tacrolimus) Ointment Vs. Elidel (Pimecrolimus) Cream in Patients With Atopic Dermatitis

A study to compare efficacy of Protopic Ointment to that of Elidel Cream in treating patients with Atopic Dermatitis

Inclusion Criteria:

• Diagnosis of Atopic Dermatitis rated at least mild using the Investigator's Global Atopic Dermatitis Assessment involving a minimum of 5% of the body surface area
• Negative pregnancy test and agrees to practice effective birth control during the study

Exclusion Criteria:

• Skin disorder other than Atopic Dermatitis in the areas to be treated
• Extensive scarring or pigmented lesions in the areas to be treated that would interfere with rating of efficacy parameters
• Clinically infected Atopic Dermatitis at baseline
• Likely to require systemic corticosteroids; or likely to require intranasal or inhaled corticosteroids for an off-label indication or at higher doses than the maximum labeled dosing for the drug
• Known hypersensitivity to macrolides or any excipient of either study medication
• Chronic condition which is either not stable or not well controlled
• Pregnant or breast feeding an infant